Lulu Xue | Drug | Innovative Research Award

Innovative Research Award

Lulu Xue
Affiliation Nanjing University
Country China
Scopus ID 56310961600
Documents 52
Citations 2,918
h-index 28
Subject Area Drug
Event International Research Chemistry Awards
ORCID 0000-0001-5719-1336

Lulu Xue is a researcher affiliated with Nanjing University, China, whose documented scholarly profile includes research documents, citations, and an h-index. The profile identifies Drug as the principal subject area. These bibliometric indicators provide a quantitative description of research activity and scholarly visibility and are considered here as part of an academic recognition profile rather than as an independent measure of research quality.[1]

Abstract

This article documents the academic recognition profile of Lulu Xue of Nanjing University, China, in connection with the Innovative Research Award of the International Research Chemistry Awards. The supplied research record identifies documents, citations, and an h-index, with Drug listed as the principal subject area. The profile is considered from the perspective of scholarly productivity, citation impact, research relevance, and potential contribution to drug-related chemical research.[1]

Keywords

Lulu Xue of Nanjing University contributes to drug research, medicinal chemistry, and drug discovery through chemical research. Her scholarly profile supports recognition under the Innovative Research Award of the International Research Chemistry Awards, reflecting sustained academic activity and contributions to advancing chemistry-based approaches relevant to pharmaceutical research and scientific innovation.[1]

Introduction

Drug-oriented chemical research encompasses the discovery, design, synthesis, characterization, evaluation, and optimization of chemical entities with potential biological activity. Medicinal chemistry is closely connected with chemical biology, pharmacology, analytical chemistry, and related disciplines, requiring integration of molecular structure, physicochemical properties, biological activity.[2]

Research Profile

The supplied profile associates Lulu Xue with Nanjing University in China and identifies Drug as the relevant subject area. The record contains documents, indicating a substantial body of indexed scholarly output. A citation count of and an h-index further indicate that the publications have received considerable attention within the indexed research literature.[2]

Research Contributions

A contribution in this area may involve the generation of new chemical knowledge, development or optimization of molecular structures, investigation of chemical mechanisms, or application of chemical methodologies to problems in drug discovery and development. Assessment of individual contributions should be based on the scientific content of the corresponding publications and supporting evidence.[3]

Publications

The supplied profile records documents for Lulu Xue. This figure indicates a substantial indexed publication record, although the available input does not provide the individual publication titles, journals, publication years, authorship positions, or article-level citation data. Accordingly, this article does not attribute specific scientific findings to individual publications without corresponding bibliographic evidence.[4]

Research Impact

The supplied citation count of and h-index indicate that the research outputs associated with the supplied Scopus author record have accumulated substantial scholarly citation activity. Citation-based measures can assist in describing the visibility and influence of a research portfolio, but citation frequency varies considerably among disciplines, publication types, research topics, and publication ages. They should therefore be interpreted together with qualitative evidence.[2]

Award Suitability

Based on the information supplied, Lulu Xue presents a research profile that is compatible with consideration for an Innovative Research Award within a chemistry-focused recognition program. The combination of a drug-related subject area, documented research documents, citations, and an h-index of provides measurable evidence of sustained scholarly activity and research visibility.[3]

Conclusion

Lulu Xue of Nanjing University is presented in the supplied academic record as a researcher working in the Drug subject area, with documents, citations, and an h-index . These indicators describe a substantial scholarly publication and citation record and provide quantitative context for consideration within the Innovative Research Award category.[4]

References

    1. Elsevier. (n.d.). Scopus author details: Lulu Xue, Author ID 56310961600. Scopus.
      https://www.scopus.com/authid/detail.uri?authorId=56310961600
    2. ORCID. (n.d.). ORCID record: Lulu Xue, ORCID iD 0000-0001-5719-1336. ORCID.
      https://orcid.org/0000-0001-5719-1336
    3. International Research Chemistry Awards. (n.d.).
      https://researchchemistry.org
    4. Gu, Z., Xiong, X., Chen, X., Zhang, H., Gu, N., & Xue, L. (2026). Ligand-mediated reprogramming redirects liver-tropic ionizable lipid nanoparticles for lung-selective mRNA delivery. Angewandte Chemie International Edition.
      https://doi.org/10.1002/anie.6080664

Kushagra Khanna | Pharmacy | Innovative Research Award

Innovative Research Award

Kushagra Khanna
Affiliation UCSI University
Country Malaysia
Scopus ID 57213100648
Documents 57
Citations 898
h-index 16
Subject area Pharmacy
Award Innovative Research Award
Event International Research Chemistry Awards
ORCID 0000-0002-1882-2120

Kushagra Khanna is a researcher affiliated with UCSI University, Malaysia, whose stated subject area is pharmacy. The supplied bibliometric profile records documents, citations and an h-index. These indicators provide a quantitative overview of the research output and citation activity associated with the supplied Scopus author profile. The researcher is recognized in connection with the Innovative Research Award under the International Research Chemistry Awards. The award profile highlights the importance of research innovation, scientific contributions and the advancement of pharmaceutical knowledge.[1]

Abstract

This article presents an academic recognition profile for Kushagra Khanna of UCSI University, Malaysia, in the subject area of pharmacy. The profile is associated with the Innovative Research Award presented under the International Research Chemistry Awards. According to the supplied Scopus information, the researcher has 57 documents, 898 citations and an h-index.[1]

Keywords

Kushagra Khanna; Pharmacy Research; Pharmaceutical Sciences; Innovative Research Award; Pharmaceutical Innovation; Drug Discovery; Clinical Pharmacy; Research Impact; Bibliometrics; Citation Analysis; UCSI University; Malaysia; Scopus Author Profile; ORCID Profile; International Research Chemistry Awards.[2]

Introduction

Pharmacy is a multidisciplinary field concerned with medicines, their development, formulation, safe use and therapeutic applications. Research in this area can connect pharmaceutical sciences with healthcare delivery, pharmacology, drug analysis, medication safety and emerging therapeutic technologies.[1]

Research Profile

The supplied profile identifies Kushagra Khanna with UCSI University, Malaysia, and designates pharmacy as the relevant subject area. The provides a persistent route to the researcher’s indexed author record, while the supports identification of the researcher’s scholarly identity. These identifiers can help readers distinguish an author’s record from similarly named researchers and locate associated academic information .[5]

Research Contributions

Pharmacy research encompasses a broad range of scientific and professional activities, including the investigation of drug properties, pharmaceutical formulations, therapeutic effectiveness, medicine quality and the responsible use of medicines. Depending on the researcher’s documented publication record, contributions in these areas may include experimental studies, analytical methods, literature reviews, translational investigations or collaborative research.[4]

Publications

The supplied Scopus profile records documents associated with the researcher. This document count indicates indexed scholarly output in the source profile, but the figure alone does not establish the types of publications, authorship positions, publication venues or specific scientific findings. Those details should be assessed by reviewing the individual records and their full bibliographic information.[2]

Research Impact

The supplied bibliometric indicators for Kushagra Khanna comprise documents, citations and an h-index. In bibliometric analysis, document counts summarize indexed output, citation counts measure recorded citations, and the h-index combines publication volume with citation frequency. These indicators describe different aspects of scholarly activity and should be interpreted together with subject context and publication-level evidence.[3]

Award Suitability

The profile associates Kushagra Khanna with the Innovative Research Award under the International Research Chemistry Awards. Within the context of pharmacy and pharmaceutical sciences, research innovation may involve new scientific approaches, improved methods, interdisciplinary investigations or evidence that advances understanding of medicines and their applications.[4]

Conclusion

Kushagra Khanna is identified in the supplied information as a pharmacy researcher affiliated with UCSI University, Malaysia, and associated with the Innovative Research Award under the International Research Chemistry Awards. The profile records documents, citations and an h-index. These figures provide a quantitative snapshot of indexed scholarly activity, while a fuller understanding of the researcher’s contributions requires examination of individual publications and verifiable evidence.[5]

References

    1. Elsevier. (n.d.). Scopus author details: Kushagra Khanna, Author ID 57213100648. Scopus. Author profile and bibliometric information should be consulted for current records.
      https://www.scopus.com/authid/detail.uri?authorId=57213100648
    2. ORCID. (n.d.). ORCID record: 0000-0002-1882-2120. ORCID provides a persistent identifier for distinguishing researchers and connecting scholarly contributions.
      https://orcid.org/0000-0002-1882-2120
    3. International Research Chemistry Awards. (n.d.).
      https://researchchemistry.org
    4. Kumar, P., Khanna, K., Dhiani, B. A., Tan, L. F., Yap, V. L., Chow, J. C., & Kaur, C. P. (2026). Targeting uterine fibroid cells with TC-16A: A polyherbal formulation based strategy involving apoptosis, cell cycle arrest, and autophagy. South African Journal of Botany, 196, 477–488.
      https://doi.org/10.1016/j.sajb.2026.04.040
    5. Karwasra, R., Bano, N., Ahmad, S., Singh, S., Khanna, K., Sharma, N., Raza, K., & Verma, S. (2026). Multimodal evaluation of mannose engineered poly lactic glycolic acid nanoparticles with granulocyte colony stimulating factor focused delivery to bone marrow for neutropenia. Scientific Reports, 16, Article 2849.
      https://doi.org/10.1038/s41598-025-29790-w

Mrs. Kathrin Schön, Pharmaceutical Chemistry, Best Researcher Award

Mrs. Kathrin Schön, Pharmaceutical Chemistry, Best Researcher Award

Mrs. Kathrin Schön, CSL Behring Innovation GmbH, Marburg, Germany, Germany

Profile

Orcid

Summary 📋

Dr. Kathrin Schön is a dedicated medical professional specializing in human genetics. With extensive experience in genetic counseling, molecular genetics, and cytogenetic analysis, she combines her clinical expertise with a robust research background in pharmacology and toxicology.

Education 🎓

Medicine (10/2013 – 11/2021), Philipps University Marburg
Licence to practise medicine on December 08, 2021

MD Thesis (03/2018 – ongoing), CSL Behring Innovation GmbH, Marburg
“Characterization of rFIX fusion proteins enabling subcutaneous administration”

Professional Experience 🏥

Physician in Human Genetics (since 07/2023), IMD Humangenetik Wiesbaden

Genetic counseling, examination, molecular genetic analysis, and cytogenetic laboratory work

Medical Affairs Trainee (10/2022 – 04/2023), Dr. Reiner Rittinghausen GmbH

Account management and sales

Physician (01/2022 – 08/2022), Local Health Department′s Coronavirus Faculty, Marburg

Consultant (01/2020 – ongoing), Clinical Development, CSL Behring Innovation GmbH

MD Thesis Doctoral Student (03/2018 – ongoing), CSL Behring Innovation GmbH, Marburg

Research Interests 🔬

Human Genetics: Genetic counseling and molecular genetic analysis

Pharmacology & Toxicology: Characterization of recombinant Factor IX fusion proteins

Hematology and Oncology: Clinical studies and patient care in hematology and oncology

Publications📚

Characterization of recombinant Factor IX fusion proteins enabling subcutaneous administration

Authors: Kathrin Schön, Sabine Pestel, Julia Riedesel, Waltraud Seyfert-Brandt, Philipp Claar, Eva Herzog, Alireza Rezvani-Sharif, Padmapriya Ponnuswamy, Marc W. Nolte

Journal: Journal of Thrombosis and Haemostasis

Year: 2024

Patient‐physician interactions in hereditary angioedema—Key learnings from the coronavirus disease 2019 pandemic

Authors: Maurer M, Buttgereit T, Magerl M, Schön K, Balla Z, Farkas H

Journal: Clinical and Translational Allergy

Year: 2023

Conference Poster: Characterization of rFIX fusion proteins enabling subcutaneous administration

Authors: Kathrin Schön, J. Riedesel, W. Seyfert-Brandt, S. Pestel, M. Mischnik, W. Azar, W. Hardy, M.W. Nolte, P. Claar

Journal: 65th Annual Meeting of the Society of Thrombosis and Hemostasis Research

Year: 2021